X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs ALKEM LABORATORIES - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD ALKEM LABORATORIES MERCK LTD/
ALKEM LABORATORIES
 
P/E (TTM) x 33.3 - - View Chart
P/BV x 3.7 7.4 50.6% View Chart
Dividend Yield % 0.8 0.6 128.9%  

Financials

 MERCK LTD   ALKEM LABORATORIES
EQUITY SHARE DATA
    MERCK LTD
Dec-16
ALKEM LABORATORIES
Mar-16
MERCK LTD/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,0601,589 66.7%   
Low Rs6231,232 50.6%   
Sales per share (Unadj.) Rs632.4417.5 151.5%  
Earnings per share (Unadj.) Rs45.756.3 81.2%  
Cash flow per share (Unadj.) Rs62.364.7 96.3%  
Dividends per share (Unadj.) Rs11.0012.70 86.6%  
Dividend yield (eoy) %1.30.9 145.2%  
Book value per share (Unadj.) Rs388.8292.9 132.7%  
Shares outstanding (eoy) m16.60119.57 13.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.33.4 39.4%   
Avg P/E ratio x18.425.1 73.5%  
P/CF ratio (eoy) x13.521.8 62.0%  
Price / Book Value ratio x2.24.8 44.9%  
Dividend payout %24.122.6 106.7%   
Avg Mkt Cap Rs m13,969168,653 8.3%   
No. of employees `0001.6NA-   
Total wages/salary Rs m1,4879,171 16.2%   
Avg. sales/employee Rs Th6,631.9NM-  
Avg. wages/employee Rs Th939.2NM-  
Avg. net profit/employee Rs Th479.4NM-  
INCOME DATA
Net Sales Rs m10,49849,915 21.0%  
Other income Rs m2421,645 14.7%   
Total revenues Rs m10,74151,561 20.8%   
Gross profit Rs m1,1358,482 13.4%  
Depreciation Rs m2761,006 27.4%   
Interest Rs m0671 0.0%   
Profit before tax Rs m1,1028,451 13.0%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3431,606 21.4%   
Profit after tax Rs m7596,731 11.3%  
Gross profit margin %10.817.0 63.6%  
Effective tax rate %31.119.0 163.9%   
Net profit margin %7.213.5 53.6%  
BALANCE SHEET DATA
Current assets Rs m6,41027,062 23.7%   
Current liabilities Rs m8,82815,324 57.6%   
Net working cap to sales %-23.023.5 -98.0%  
Current ratio x0.71.8 41.1%  
Inventory Days Days5867 86.7%  
Debtors Days Days3841 93.0%  
Net fixed assets Rs m1,40612,610 11.2%   
Share capital Rs m166239 69.4%   
"Free" reserves Rs m6,28634,490 18.2%   
Net worth Rs m6,45535,027 18.4%   
Long term debt Rs m01,212 0.0%   
Total assets Rs m8,82854,387 16.2%  
Interest coverage xNM13.6-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.20.9 129.6%   
Return on assets %8.613.6 63.2%  
Return on equity %11.819.2 61.2%  
Return on capital %17.124.9 68.7%  
Exports to sales %8.312.9 64.0%   
Imports to sales %21.03.1 681.9%   
Exports (fob) Rs m8696,461 13.5%   
Imports (cif) Rs m2,2091,540 143.4%   
Fx inflow Rs m9596,563 14.6%   
Fx outflow Rs m2,6123,012 86.7%   
Net fx Rs m-1,6533,552 -46.5%   
CASH FLOW
From Operations Rs m1,0707,259 14.7%  
From Investments Rs m-7501,864 -40.2%  
From Financial Activity Rs m-150-9,273 1.6%  
Net Cashflow Rs m171-150 -113.9%  

Share Holding

Indian Promoters % 0.0 66.9 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 33.1 55.0%  
FIIs % 1.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 0.0 -  
Shareholders   28,591 68,381 41.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  FULFORD INDIA  ALEMBIC PHARMA  AJANTA PHARMA  

Compare MERCK LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Feb 16, 2018 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE MERCK LTD WITH

MARKET STATS